MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Putaminal dopamine modulates movement motivation in Parkinson’s disease

M. Banwinkler, V. Dzialas, L. Rigoux, H. Theis, A. Asendorf, K. Giehl, M. Tittgemeyer, M. Hoenig, T. van Eimeren (Cologne, Germany)

Meeting: 2024 International Congress

Abstract Number: 1804

Keywords: Dopamine, Hypokinesia, Motor control

Category: Parkinson's Disease: Pathophysiology

Objective: To investigate the quantitative effect of dopamine depletion on the motivation of motor effort in Parkinson’s disease.

Background: The relative inability to produce effortful movements (akinesia) is the most specific motor sign of Parkinson’s disease. The motor motivation hypothesis suggests that akinesia may not reflect a deficiency in motor control per se, but a deficiency in motivation for motor effort.

Method: 21 patients with Parkinson’s disease and 26 matched healthy controls were included. An incentivized force task [figure1] was used to capture the amount of effort participants were willing to invest for different monetary incentive levels and dopamine transporter depletion in the bilateral putamen was assessed.

Results: We demonstrate that patients with Parkinson’s disease applied significantly less grip force than healthy controls, especially for low incentive levels [figure2]. Congruously, decrease of motor effort with greater loss of putaminal dopaminergic terminals was most pronounced for low incentive levels [figure3]. This signifies that putaminal dopamine is most critical to motor effort when the trade-off with the benefit is poor.

Conclusion: Taken together, we provide direct evidence that the reduction of effortful movements in Parkinson’s disease depends on motivation and that this effect is associated with putaminal dopaminergic degeneration.

Behavioral incentivized force task

Behavioral incentivized force task

Peak grip force in PD and HC per incentive level

Peak grip force in PD and HC per incentive level

Interaction: grip force, DA and incentive level

Interaction: grip force, DA and incentive level

To cite this abstract in AMA style:

M. Banwinkler, V. Dzialas, L. Rigoux, H. Theis, A. Asendorf, K. Giehl, M. Tittgemeyer, M. Hoenig, T. van Eimeren. Putaminal dopamine modulates movement motivation in Parkinson’s disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/putaminal-dopamine-modulates-movement-motivation-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/putaminal-dopamine-modulates-movement-motivation-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley